Saliva Antigen Test Kit

15-20 Minutes 70mm SARS-CoV-2 Antigen Self Test Set Saliva Sample Collector Japan 1 test/box Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. What is a rapid

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name SARS

15-20 Minutes Plastic SARS-CoV-2 Antigen Self Test Set Saliva Sample Collector Japan 1 test/box This COVID-19 rapid antigen lateral flow home-testing kit is the ideal solution if you are travelling to one of the many countries that now accept antigen tests for entry (check the entry requirements for your destination country here). These tests are very quick and simple to administer, and fully Home Use approved. They differ from your usual nasopharyngeal lateral flow COVID-19

15-20 Minutes 99% Accuracy SARS-CoV-2 Antigen Self Test Set Saliva Sample Collector Japan 1 test/box The SARS-CoV-2 Rapid Antigen Test is a reliable, rapid chromatopgraphic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx. This test is an aid in detecting antigen from the SARS-CoV-2 virus in individuals suspected of COVID-19. This product is strictly intended for professional use in laboratory and Point of Care

99% Accuracy 2 years Shelf Life SARS-CoV-2 Antigen Self Test Set Saliva Sample Collector Thailand 1 test/box Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Product name Salive Rapid Antigen Test

99% Accuracy Factory price SARS-CoV-2 Antigen Self Test Set Saliva Sample Collector Malaysia 1 test/box This product is a rapid, lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens from anterior nasal swabs that are self-collected by an individual aged 18 years or older or are collected by an adult from an individual younger than 18 years old. This test is intended for use in individuals with symptoms or other epidemiological

99% Accuracy Fast reaction rapid SARS-CoV-2 Antigen Self Test Set Saliva Sample Collector Malaysia 1 test/box Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status

Class III 2 years Shelf Life SARS-CoV-2 Antigen Self Test Set Saliva Sample Collector Japan 1 test/box How accurate will the antigen test be? The accuracy of COVID-19 Antigen Tests can be measured by two factors. Sensitivity, which measures the ability to correctly identify positive patient samples. If a test kit has a high sensitivity, it means that the kit has a high positive percentage agreement and a low false negative rate. Specificity, which measures the ability to

15-20 Minutes Factory price SARS-CoV-2 Antigen Self Test Set Saliva Sample Collector Japan 1 test/box Features 15-minute rapid detection Easy-to-operate coronavirus antigen test Less-invasive nasal (NS) swab sample collection CE-IVD marked Available in 1/2/5/20 tests/box Nasopharyngeal swab and saliva versions available Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens

70mm Factory price SARS-CoV-2 Antigen Self Test Set Saliva Sample Collector Thailand 1 test/box Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. The SARS-CoV

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet Brand

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Date sheet

Description Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.